Capillary Blood Collection Devices Market Research Report 2023 - 2030

 

Market Summery

Acknowledging the impressive growth records, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Capillary Blood Collection Devices market share will register a staggering CAGR of 6.20% from 2022-2030, witnessing the accruals of approx. 790 Mn. USD by 2030.

Capillary Blood Collection Devices, the equipment used to collect the blood samplings for diagnosis and test purposes are integral to obtain high-quality clinical results. These devices are vastly preferred among clinicians and patients due to its simple and painless blood collection technique. 

Growing prevalence of chronic diseases and disorders such as vascular, diabetes, and heart diseases drive the market growth, increasing the demand for diagnosis and the uptake of these devices.  Resultantly, the global capillary blood collection devices market research is garnering huge traction, growing pervasively.

Undoubtedly, technological advancements transpired in the field of medical devices as a foray to bring more innovations in these devices are boosting the market growth, escalating the market to the exceeding heights.

Conversely, high prices of these devices is a predominant factor impeding the market growth. Also, the risk associated with the blood collection techniques and contaminations are hampering the market growth of the capillary blood collection devices market. Nevertheless, recent betterments taken place in these devices as a result of forays of the market players are increasing the demand for these devices by the physicians and patients, contributing to the market growth to a great extent, in turn.

Capillary Blood Collection Devices Market – Competitive Landscape

The global market appears to be highly competitive and diversified with the presence of giant manufacturers of the devices, playing on the global level. These players are heavily investing in R&D, global expansion, advanced technologies and product Launch to gain the competitive edge in the market. 

Key Players:

Capillary blood collection devices market players include – Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A., Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group, Weihai Hongyu Medical Devices, and Medigard. Profiling them in its analysis, MRFR finds out their strategies keeping them ahead in the market competition.

Capillary Blood Collection Devices Market – Segments

The MRFR analysis is segmented into four key dynamics for the convenience of the report and enhanced understanding;

By Material     s                      : Comprises Glass, Plastic, and Stainless Steel, among others.

By Types of Devices   : Warming Devices, Blood Collecting Tubes & Collector, and Lancets, among others.

By End-Users              : Hospitals, Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories, among others.

By Regions                              :  North America,   Europe, APAC and Rest-of-the-World.

The Plastic segment by the materials is projected to acquire 42.3% of the market share which will be the largest share. The segment will register 10.4% CAGR during the review period 2017–2023.

The Blood Collecting Tubes and Collector segment is expected to acquire 48.4% of the market share over the review period which will be the largest share based on the types of devices

The Lancets Segment is projected to grow at a CAGR of 10.4% between 2017–2023.

Capillary Blood Collection Devices Market – Regional Analysis

North America Capillary Blood Collection Devices market trends backed by the presence of well-established players & investments, accounts for the leading market, globally, holding the largest market share. Companies involved in the manufacturing of these devices are well capable of delivering a range of customized solutions. Furthermore, augmented uptake of software solutions for healthcare administration and availability of complimenting resources drive the market growth in the region.

Factors substantiating the market growth include growing number of patients suffering from chronic diseases & disorders that consecutively augments the demand for diagnosis, increasing demand for technologically advanced diagnosis and treatment, rising government support and high per capita health care expenditures in the region. The market value is estimated to settle at US$ 292.96 Mn. by 2023.

The Europe market stands the second largest market for capillary blood collection devices, globally, owing to the technological advancement and the augmented adoption of these devices among the healthcare providers mainly in the UK, Germany, and France coupled with the resurging economy in the region which is improving the consumers’ quality of life by increasing their purchasing power.  

The market is expected to demonstrate a healthy growth during the forecast period owing to the factors such as public & private funding for R&D, the presence of leading market players and increasing prevalence of diabetes, in the region. 

Additional factors such as the availability of advent & advanced treatment facilities & healthcare expenditures along with the growing demand for better healthcare infrastructure are fuelling the market growth in the region.  Also, factors such as the ever increasing population that is increasingly adopting the sedentary lifestyle are driving the growth of the Europe market.

The Asia Pacific market stands the third position emerging as one of the promising markets for Capillary Blood Collection Devices. Factors such as, availability of new diagnosis and treatment methods, increasing prevalence of chronic diseases like diabetes and the growing population that is increasingly gaining awareness towards the benefits of health management, foster the market growth in the region.  The APAC market is estimated to grow at 10.6% CAGR during 2017–2023.

The Middle East & Africa region, on the other hand, is expected to experience a plateau phase in the growth primarily due to the African market where lack of awareness, limited access and availability of treatment facilities are some of the factors responsible for the restricted growth. While the Middle East region is expected to a steady growth owing to the well-developed healthcare sector that is increasingly availing specialty care centers. UAE among other MEA countries draws the largest market share in the region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Patient registry software market: In-depth Research with Industry Rapidly Boost in Future Forecast To 2030

 

• North America Market is the largest for patient registry software, accounting for the largest share of the market in 2022. This is due to the increasing prevalence of chronic diseases in the region, as well as the growing adoption of electronic health records (EHRs). The US is the largest market in North America, followed by Canada.
• Europe Market is the second largest for patient registry software. The market in Europe is driven by the increasing demand for patient-centered care, as well as the growing focus on population health management. Germany is the largest market in Europe, followed by the UK and France.
• Asia Pacific Market is the third largest market for patient registry software. The market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This is due to the rising prevalence of chronic diseases in the region, as well as the growing investment in healthcare infrastructure. China is the largest market in Asia Pacific, followed by Japan and India.

Here are some of the key drivers and trends in the patient registry software market:

• Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is driving the demand for patient registry software. This is because patient registry software can be used to track the progress of patients with chronic diseases, as well as to identify patients who are at risk of developing complications.
• Growing adoption of EHRs: The growing adoption of EHRs is also driving the demand for patient registry software. EHRs can be used to collect and store patient data, which can then be used to create and manage patient registries.
• Growing focus on population health management: There is a growing focus on population health management in the healthcare industry. This is because it is more cost-effective to manage the health of a population than to treat individual patients who are sick. Patient registry software can be used to collect data about a population of patients, which can then be used to identify and address health risks.
• Rising awareness about the benefits of patient registry software: There is a growing awareness about the benefits of patient registry software among healthcare providers and patients. This is because patient registry software can be used to improve the quality of care, reduce costs, and improve patient outcomes.

 

Related Charts:

South America Patient Registry Software Market Forecast (2016-2025)

Middle East and Africa Patient Registry Software Market By Functionality Forecast (2016-2025)

About Us

Wantstats Research and Media Pvt Ltd is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. WRMPL’s approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Our fast growing industry research firm is backed by a proficient team of research analysts that offers valuable analytics and data with respect to technological and economical advancements. Our deemed analysts perform industrial visits and procure the relevant information from prominent market players. Our key objective is to keep our clients abridged of the potential opportunities and challenges in different markets. We provide step-by-step assistance to our respected clients, via strategic and consulting services to reach a managerial and actionable decision.

Contact Details

Corporate Office (India)

WantStats Research and Media Pvt. Ltd.

Office No 104, Pentagon 4,

Magarpatta City, Pune - 411028

Maharashtra, India.

Sales: +1 (855) 661-4441 (US)   +44 1720 412 167(UK)

Asia Pacific Arrhythmia Monitoring Devices Market: Growth, Trends, and Forecasts

 Asia Pacific Arrhythmia Monitoring Devices Market are abnormal heart rhythms that can be caused by a variety of factors, including heart disease, electrolyte imbalance, and medication side effects. Arrhythmias can be mild and cause no symptoms, or they can be severe and lead to life-threatening complications, such as stroke or heart failure.

Arrhythmia monitoring devices are used to track and record heart rhythms over a period of time. This information can be used to diagnose arrhythmias, assess their severity, and develop treatment plans. Arrhythmia monitoring devices come in a variety of forms, including Holter monitors, event monitors, and implantable cardiac monitors.

The Asia-Pacific region is home to a large and growing population of people with arrhythmias. According to the World Health Organization, the prevalence of arrhythmias in the region is estimated to be 10%. The increasing awareness about the benefits of arrhythmia monitoring devices and the growing geriatric population are driving the growth of the market in the region.

Browse full report-Asia Pacific Arrhythmia Monitoring Devices Market Overview

The key players in the Asia Pacific cardiac arrhythmia monitoring devices market are:

• Abbott
• Medtronic
• Boston Scientific
• Nihon Kohden
• AliveCor
• BioTelemetry
• Cardionet
• LifeWatch
• Preventice Solutions
• Qardio
• Tenex Medical

These companies are developing innovative arrhythmia monitoring devices to meet the needs of patients and healthcare providers in the region.

The market is also expected to be driven by the increasing adoption of telehealth solutions. Telehealth solutions allow patients to remotely monitor their heart rhythms and receive care from healthcare providers. This is a convenient and cost-effective way to manage arrhythmias.

The Asia Pacific arrhythmia monitoring devices market is a fragmented market. The key players are competing on the basis of product innovation, features, and pricing. The market is expected to witness new product launches and partnerships in the coming years.

Related Charts-

South America Arrhythmia Monitoring Devices Market By Application Forecast (2016-2024)

Europe Arrhythmia Monitoring Devices Market By Application Forecast (2016-2024)

North America Arrhythmia Monitoring Devices Market By Application Forecast (2016-2024)

 

About Us

Wantstats Research and Media Pvt Ltd is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. WRMPL’s approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.

Our fast growing industry research firm is backed by a proficient team of research analysts that offers valuable analytics and data with respect to technological and economical advancements. Our deemed analysts perform industrial visits and procure the relevant information from prominent market players. Our key objective is to keep our clients abridged of the potential opportunities and challenges in different markets. We provide step-by-step assistance to our respected clients, via strategic and consulting services to reach a managerial and actionable decision.

Contact Details

Corporate Office (India)

WantStats Research and Media Pvt. Ltd.

Office No 104, Pentagon 4,

Magarpatta City, Pune - 411028

Maharashtra, India.

Sales: +1 (855) 661-4441 (US)   +44 1720 412 167(UK)

Infertility Market Overview Analysis By Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2032

 

Market Summery

Infertility is a medical condition in which male or female members are unable to reproduce or have children. Common conditions for the condition include low sperm motility, genetic deficiencies, and psychological issues. According to the Centers for Disease Control & Prevention (CDC), close to 6% unmarried women are unable to attain pregnancy even after unprotected intercourse. The global infertility market report compiled by Market Research Future (MRFR) contains pertinent factors and challenges of customers as well as efforts of industry stalwarts in easing the process of reproduction.

The Infertility Market Overview is anticipated to grow at CAGR of 12.8 % and will reach a valuation of USD 4.72 billion during the forecast period 2023-2032.

Major growth drivers of the market include late marriages, sedentary lifestyles, genetic deficiencies, environmental factors, and health history.

Market Outlook

Awareness of the condition and preventive measures in terms of treatment is likely to drive the market growth. Emergence of various clinics which can conduct tests discreetly can bode well for the market. In addition, the recognition of infertility as a disease by insurance organizations and coverage packages being dispensed to patients is a sign of the large potential of the market. Technological advances in terms of artificial reproduction technique (ART) and artificial insemination are predicted to bolster the global infertility market growth. Successful outcomes of such methods as well as conduction of clinical trials for safe methods of conception among couples are other major drivers of the market.

High Infertility treatment costs, side effects of infertility treatment, and societal taboos are factors which can impede market growth.

Competitive Outlook-

           ·          SCSA Diagnostics, Inc.,

           ·          Bayer Healthcare,

           ·          EMD Serono, Inc.,

           ·          Zydus Cadila Healthcare Ltd,

           ·          Aetna Inc.,

           ·          Androvia LifeSciences,

           ·          Andrology Solutions,

           ·          Halotech DNA,

and others are prominent names within the global infertility market players.

Segmentation Analysis

The global infertility market report is segmented by sex, diagnosis, drugs, and techniques.

·         By sex, it is segmented into male, female, and unexplained.

·         By diagnosis, it is segmented into men diagnostic tests, female diagnostic tests, and general diagnostic tests. Testicular biopsy, genetic testing, semen analysis, and others are major sub-segments within the men diagnostic tests segment. Female diagnostic tests, on the other hand, is segmented into hysterosalpingography, hysteroscopy, laparoscopy, ovulation testing, and others. Microscopic analysis, imaging, hormone testing, genetic testing, and others are segments within general diagnostic tests.

·         By drugs, it is segmented into seraphine, clomiphene citrate, letrozole, hormone treatment, and others.

·         By techniques, it is segmented into assisted reproductive technology (ART), surgery, and intrauterine insemination. Surgery is further segmented into tubal surgeries, laparoscopic or hysteroscopic surgery, and others.

Regional Analysis

North America, Asia Pacific, Europe, and the Middle East & Africa (MEA) are the regions being considered for the basis of the report.

North America is predicted to dominate the market led by the U.S. Factors facilitating regional market growth include rise in awareness levels of patients, high expendable income levels of patients, and reimbursement schemes.

Europe is expected to be the second largest region led by France, Germany, and the U.K. Changes in lifestyles of patients and delayed pregnancies are factors which can drive the need for fertility treatments. In addition, the successful outcomes of fertility clinics as well as rise in cryopreservation can contribute to the global infertility treatment in paris.

Industry News

·         Seed funding to accelerate research and development efforts put into fertility treatments is expected to increase due to successful outcomes as well as demand for affordable treatment methods. Recently, Mojo is planning to raise USD 1.8 million in capital with the help of Nordic firm, Inventure. The firm plans to use robotics and artificial intelligence to assist in egg and sperm quality analysis as well as develop methods to lower fertilization costs.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Apheresis Market Overview Analysis 2030: In-Depth Research on Industry Size, Current and Emerging Growth Factors by 2030

 

Market Scenario

The global apheresis market is projected to grow at a 8.90 % CAGR during the forecast period (2023-2030), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR). Apheresis is referred to as the procedure of separating and purifying the blood for treating several renal, neurological, autoimmune, hematological, and other diseases. Apheresis involves removal of the blood from the donor or patients and collecting it into an apparatus which separates the component from the blood. The rest of the blood is sent to the patients or the donors. The separation is mainly done using filtration and centrifugation.

Competitive Dashboard

Global apheresis market players are ; Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.

Drivers and Constraints Impacting the Market

With the growing prevalence of chronic renal diseases and blood-related diseases, the global apheresis market is considered to stimulate during the estimated period. Increasing complex surgical procedures, rising demand for different component of blood, and growing number of accidents across the globe are considered to augment the market growth in the coming years. Demand for platelets and plasma has also increased which is further impacting the global apheresis market report positively. Moreover, with continuous advancement in technology and growing need for advanced and automated devices, the market is likely to foster.

On the flip side, high cost of procedures and lack of skilled professionals are some of the major factors considered to impede the market growth in the coming years.

Global Apheresis Market: Segmental Analysis

The global apheresis market overview has been segmented on the basis of product, procedure, methods, application, end-users, and region.

By mode of product, global apheresis market has been segmented into devices and disposables. The devices segment has been further sub-segmented into platelets separators, plasma separators, and others.

By mode of procedure, the global apheresis market trends has been segmented into leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and others.

By mode of methods, the global apheresis market has been segmented into filtration and centrifugation. Among these, centrifugation is further sub-segmented into intermittent flow centrifugation, continuous flow centrifugation, and others.

By mode of application, the global apheresis market has been segmented into oncological diseases, immunological diseases, hematological diseases, cardiovascular diseases, renal diseases, neurological diseases, and others.

By mode of end-users, the global apheresis market has been segmented into hospitals, blood banks, and others.

Regional Insights

Geographically, apheresis market span across regions namely, America, Europe, Asia Pacific, and Rest-of-the-World (RoW).

Among all the regions, America is considered to hold the largest position in the global market and is expected to maintain its dominance during the assessment period. The growth is attributed to the advancement in technology and growing opportunity for apheresis products coupled with the presence of a huge patient population suffering from chronic diseases.

Asia Pacific is considered to be the fastest growing region in the global market owing to the growing demand for blood components for patients. Moreover, rapid development in the healthcare industry along with growing expenditure on health care is considered to contribute to the growth of the global market.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

 

Intrauterine Contraceptive Devices (IUCDs) Market Overview Analysis By Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2032

 

Market Highlights

The increasing awareness about contraceptive methods, increasing number of unintended pregnancies, and government support and initiatives for the prevention of unwanted abortions & pregnancies are set to drive the demand for Intrauterine Contraceptive Devices Market Report during the forecast period.

Intrauterine Contraceptive Devices Market is expected to cross USD 5.62 Billion by 2032 at a CAGR of 10.9% during the forecasted period 2023-2032.

Contraceptive devices are used to prevent unwanted pregnancy by restricting the natural ovulation cycle or making changes in the egg fertilization process. Intrauterine contraceptive devices are placed inside the uterus to avoid unintended pregnancy. These devices contain a string which guarantees the precise placement of the device inside the uterus and provide aid in removal. lifespan of these devices varies as per the brands, and it can last up to 3,5 and 10 years. Plastic and metal are used in manufacturing of intrauterine contraceptive devices (IUCDs). It is available in several shapes, such as coil, loop, triangle, and T-shaped.

Key Players

Some of the key Intrauterine Contraceptive Devices Market Players are

           ·          Bayer AG,

           ·          The Cooper Companies, Inc.,

           ·          Pfizer Inc.,

           ·          HLL Lifecare Limited,

           ·          OCON Healthcare,

           ·          SMB Corporation,

           ·          Egemen International,

           ·          EUROGINE,

           ·          S.L.,

           ·          Meril Life Sciences Pvt. Ltd.,

           ·          Mona Lisa N.V.,

           ·          Prosan International B.V.,

           ·          Pregna International Limited

Segmentation

The global intrauterine contraceptive devices (IUCDs) market overview has been segmented based on type and end user.

·         The market, based on type, has been divided into a hormonal intrauterine device and copper intrauterine device. Copper intrauterine devices are likely to hold the maximum market share in the global intrauterine contraceptive devices (IUCDs) market.

·         The end user segment of the market consists of hospitals, gynecology clinics, community health care centers, and others. The hospitals segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and undergoing medical procedures.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Asia-Pacific is anticipated to hold the largest market share. The intrauterine contraceptive devices (IUCDs) market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the presence of a large patient pool, developing the healthcare sector, and raising awareness about intrauterine contraceptive devices the region.

The Americas is anticipated to be the fastest-growing market owing to the rising number of unintended pregnancies, well-established healthcare sector, and increasing healthcare expenditure. The intrauterine contraceptive devices (IUCDs) market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.

The European intrauterine contraceptive devices (IUCDs) market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The intrauterine contraceptive devices (IUCDs) market in the Middle East & Africa has been divided into the Middle East and Africa.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Dental Surgical & Diagnostic Devices Market Overview Analysis 2032: In-Depth Research on Industry Size, Current and Emerging Growth Factors by 2032

 

Market Analysis

The global dental surgical & diagnostics devices market share is projected to reach USD 11.33 Billion by 2032 at a CAGR of 8.2% over the forecast period of 2023-2032, reveals Market Research Future (MRFR) in a minutely analyzed research report.

 

Increasing prevalence of dental problems is the primary factor in boosting the growth of the market. Unhealthy eating habits among individuals result in tooth problems such as tooth decay, gum disease, cavities, etc. induce high demand for screening and treatment which drives the market for dental surgical and diagnostics devices. Increased affinity for cosmetic dentistry is also a notable factor influencing the growth of the market.

 

The rapid increase in global geriatric population is likely to fuel the growth of the global dental surgical & diagnostics market. The elderly populace is at more risk of suffering from dental problems more frequently than other age groups which generate demand for surgical and diagnostics products.

 

The growing trend of dental tourism has been instrumental in shaping the growth of the global dental surgical and diagnostics devices market. Healthcare costs mounting to unreasonable peaks in developed countries have encouraged dental tourism in developing countries such as India which augments the growth of the market.

 

The market is further propelled by developments made in the field of dental instruments, innovations in products and developments in surgical techniques which are anticipated to push the market ahead over the forecast period. Dental laser, oral radiology and other significant developments achieved in the field of dentistry along with the development of minimally invasive procedures have spurred market growth.

 

However, the growth of the market is likely to deter by the high cost of development, and lack of proper reimbursement policies. Procedures such as cosmetic dentistry are not covered under health policies and remains a significant obstacle for the growth of the global dental surgical & diagnostics devices market report.

Competitive Landscape

Global dental surgical & diagnostics devices market players are A-dec Inc. (US), KaVo Kserr (US), Midmark Corp. (US), PLANMECA OY (Finland), American Medicals (US), Carestream Health (US), DCI (US), 3M (US), Danaher (US), GC Corporation (Japan), Hu-Friedy Mfg. Co., LLC (US), Ivoclar Vivadent AG (Liechtenstein), and Dentsply Sirona. (Germany) are the notable players operating in the dental surgical & diagnostics devices market.

 

Segmentation

The global dental surgical & diagnostics devices market overview has been segmented based on product type, application, and end users. By product type, the market has been segmented into CAD/CAM systems, dental chairs, dental radiology devices, CBCT scanners, scaling units, dental lasers. The CAD/CAM systems segment has been further segmented into full in-lab systems, stand-alone scanners, and chair-side systems.  The dental radiology devices market has been further segmented into Phosphor Storage Plates (PSP), digital x-ray, accessories, dental imaging devices. The dental lasers segment has been further segmented into soft tissue laser and all hard tissue laser market. The soft tissue laser sub-segment has been further segmented into gas laser, diode laser, and solid state lasers.

 

By application, the market has been segmented into bone abnormalities, cysts, fractures, reconstructive postmortem dental profiling, and comparative dental identification.

 

By end users, the market has been segmented into dentists, hospitals, and others.

 

Regional Analysis

The Americas, Europe, Asia Pacific, and the Middle East & Africa are the key markets for dental surgical & diagnostics devices. The Americas are at the forefront of the global dental surgical & diagnostics market insights. Presence of a vast pool of geriatric population, high expenditure on healthcare and well-developed healthcare infrastructure supports the growth of the market.

 

Europe is the second largest market for dental surgical & diagnostics devices driven by the outlay of massive amounts on the development of healthcare infrastructure.

 

Asia Pacific follows Europe closely and is slated to emerge as the fastest growing market. The Asia Pacific market stores ample growth opportunities owing to the presence of enormous population base, increasing awareness and growth of dental tourism in the region.

 

The Middle East & Africa market accounts for the least share of the market and is expected to exhibit sluggish growth over the forecast period.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America